Full Press Release Details
Change of Director s Interest
Change of Director s Interest Notice
Information or documents not available now must be
given to ASX as soon as available. Information and documents given to ASX become ASX s property and may be made public.
Introduced 30/9/2001.
Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR)
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director: Mr Matthew Lehman
Date of Last Notice: 18 June 2013
Part 1 - Change of director s relevant interests in securities
In the case of a trust,
this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph
(i) of the definition of notifiable interest of a director should be disclosed in this part.
Direct or indirect interest Direct
Nature of indirect interest N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
change 03 October 2013
No. of securities held prior to change 1) Ordinary Fully Paid Shares
Direct 1,617,763 2,104,441
Total 1,617,763 2,104,441
2) American Depositary Receipts (ADR)
+ See chapter 19 for defined terms.
11/3/2002 Appendix 3Y Page 1
Change of Director s Interest
Class 2) American Depositary Receipts (ADR) traded on the NASDAQ
= 30 ordinary fully paid shares
Number acquired 1) Ordinary Fully Paid Shares
2) American Depositary Receipts (ADR)
Number disposed Shares Options
Value/Consideration US$ 4,725.00
Note: If consideration is non-cash, provide details and estimated valuation
held after change 1) Ordinary Fully Paid Shares
Total 1,617,763 2,104,441
2) American Depositary Receipts (ADR)
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 11/3/2002
Change of Director s Interest
Nature of change Acquiring 4,500 ADR s at US$1.05 each that are traded on the NASDAQ
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 Change of director s interests in contracts
Note: In the case of a company,
interests which come within paragraph (ii) of the definition of notifiable interest of a director should be disclosed in this part.
Name of registered holder
(if issued securities)
No. and class of securities to which interest related prior to change
Note: Details are only
required for a contract in relation to which the interest has changed
Note: If consideration is non-cash, provide details and an estimated valuation
Part 3 - +Closed Period
Were the interests in the securities or
contracts detailed above traded during a +closed period where prior written clearance was required? No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
If prior written clearance was provided on what date was this provided?
+ See chapter 19 for defined terms.
11/3/2002 Appendix 3Y Page 3